SEMNUR PHARMACEUTICALS

Serial Number 86844462
606

Registration Progress

Application Filed
Dec 9, 2015
Under Examination
Jul 12, 2016
Approved for Publication
May 17, 2016
Published for Opposition
May 17, 2016
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SEMNUR PHARMACEUTICALS
Previous Owner: Semnur Pharmaceuticals, Inc.
Classes: 005

Trademark Image

SEMNUR PHARMACEUTICALS

Basic Information

Serial Number
86844462
Filing Date
December 9, 2015
Published for Opposition
May 17, 2016
Abandonment Date
August 12, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 12, 2019
Classes
005

Rights Holder

Semnur Pharmaceuticals, Inc.

03
Address
301 N. Whisman Rd, Suite 100
Mountain View, CA 94043

Ownership History

Semnur Pharmaceuticals, Inc.

Original Applicant
03
Los Altos, CA

Semnur Pharmaceuticals, Inc.

Owner at Publication
03
Mountain View, CA

Legal Representation

Attorney
Nathan E. Ferguson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

39 events
Date Code Type Description Documents
Aug 12, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 12, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 19, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 29, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 19, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 31, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 29, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 29, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
May 29, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 12, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 10, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 10, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 10, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 10, 2017 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 10, 2017 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 26, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 24, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 24, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
May 24, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 13, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 9, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 9, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 9, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 17, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 17, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 27, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 14, 2016 ALIE A ASSIGNED TO LIE Loading...
Mar 30, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 30, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 30, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 30, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 25, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 14, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 12, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain; dexamethasone sodium phosphate for medical use for use in the treatment of pain; dexamethasone sodium phosphate gel for medical use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"